Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK.

Nat Med. 1999 Mar;5(3):309-13.

PMID:
10086387
2.

Mesenchymal stem cells for bone gene therapy and tissue engineering.

Pelled G, G T, Aslan H, Gazit Z, Gazit D.

Curr Pharm Des. 2002;8(21):1917-28. Review.

PMID:
12171527
3.

Circulating endothelial/skeletal progenitor cells for bone regeneration and healing.

Matsumoto T, Kuroda R, Mifune Y, Kawamoto A, Shoji T, Miwa M, Asahara T, Kurosaka M.

Bone. 2008 Sep;43(3):434-9. doi: 10.1016/j.bone.2008.05.001. Epub 2008 May 10. Review.

PMID:
18547890
4.

Osteoblastic cells: differentiation and trans-differentiation.

Kassem M, Abdallah BM, Saeed H.

Arch Biochem Biophys. 2008 May 15;473(2):183-7. doi: 10.1016/j.abb.2008.03.028. Epub 2008 Mar 29. Review.

PMID:
18406334
5.

[Osteogenesis imperfecta--etiology, characteristics, current and future treatment].

Tarnowski M, Sieroń AL.

Wiad Lek. 2008;61(4-6):166-72. Review. Polish.

PMID:
18939369
6.
7.

Cell therapy for disorders of bone.

Jethva R, Otsuru S, Dominici M, Horwitz EM.

Cytotherapy. 2009;11(1):3-17. doi: 10.1080/14653240902753477. Review.

PMID:
19191055
8.

Mesenchymal stem cells and bioceramics: strategies to regenerate the skeleton.

Ohgushi H, Miyake J, Tateishi T.

Novartis Found Symp. 2003;249:118-27; discussion 127-32, 170-4, 239-41. Review.

PMID:
12708653
9.

Biology and clinical utilization of mesenchymal progenitor cells.

Minguell JJ, Conget P, Erices A.

Braz J Med Biol Res. 2000 Aug;33(8):881-7. Review.

10.

Mesenchymal stem cells.

Minguell JJ, Erices A, Conget P.

Exp Biol Med (Maywood). 2001 Jun;226(6):507-20. Review.

PMID:
11395921
11.

Mesenchymal stem cells. A potential source for skeletal repair.

Fibbe WE.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii29-31. Review. No abstract available.

12.
13.

Bone marrow transplantation: a new strategy for intractable diseases.

Ikehara S.

Drugs Today (Barc). 2002 Feb;38(2):103-11. Review.

PMID:
12532188
14.

The mesengenic process.

Caplan AI.

Clin Plast Surg. 1994 Jul;21(3):429-35. Review.

PMID:
7924141
15.

The function of bone marrow in the incorporation of a bone graft.

Burwell RG.

Clin Orthop Relat Res. 1985 Nov;(200):125-41. Review.

PMID:
3905105
16.

Orthopaedic and dental abnormalities in osteogenesis imperfecta: a review of the literature.

Scaramuzzo L, Raffaelli L, Spinelli MS, Damis G, Maccauro G, Manicone PF.

J Biol Regul Homeost Agents. 2011 Jul-Sep;25(3):313-21. Review.

PMID:
22023755
17.

Osteogenesis imperfecta. Perspectives.

Stoltz MR, Dietrich SL, Marshall GJ.

Clin Orthop Relat Res. 1989 May;(242):120-36. Review.

PMID:
2650946
18.

Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis.

Connolly JF.

Clin Orthop Relat Res. 1998 Oct;(355 Suppl):S257-66. Review.

PMID:
9917645
19.

Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta?

Westgren M, Götherström C.

Prenat Diagn. 2015 Sep;35(9):827-32. doi: 10.1002/pd.4611. Epub 2015 Jun 3. Review.

PMID:
25962526
20.

Diagnosis and treatment of osteopenic fractures in children.

Mehlman CT, Shepherd MA, Norris CS, McCourt JB.

Curr Osteoporos Rep. 2012 Dec;10(4):317-21. doi: 10.1007/s11914-012-0126-z. Review.

PMID:
23073639
Items per page

Supplemental Content

Write to the Help Desk